Literature DB >> 12121361

Analysis of risk factors that may be associated with progression from ocular hypertension to primary open angle glaucoma.

John Landers1, Ivan Goldberg, Stuart L Graham.   

Abstract

BACKGROUND: As a multifactorial disease, glaucoma may be associated with pressure-dependent and pressure-independent factors. Ocular hypertension (OHT) may develop into primary open angle glaucoma (POAG) for many patients. Groups with OHT and POAG were compared for pressure-dependent and independent risk factors. A high prevalence of any factor(s) could indicate a contribution to progression from OHT to POAG.
METHODS: A sample of patients with POAG (n = 438) and with OHT (n = 301) were selected from those attending a tertiary referral private glaucoma practice, and data were collected regarding age and intraocular pressure at the time of diagnosis, sex, family history of glaucoma, systemic hypertension, diabetes, Raynaud's phenomenon, migraine and myopia.
RESULTS: After multivariate analysis, older age at time of diagnosis (chi(2)(5) = 73.89, P < 0.001), myopia (odds ratio [OR] = 1.5, 95% confidence interval [CI] 1.0-2.2; P < 0.05), a family history of glaucoma (OR = 1.6, 95% CI 1.1-2.3; P < 0.01) and a high intraocular pressure (chi(2)(4) = 16.96; P = 0.002) were found to be more prevalent among those with POAG. No other significant differences could be found between the two groups.
CONCLUSION: Patients who have OHT may be at higher risk of developing POAG if they also have myopia, a family history of glaucoma or are of older age.

Entities:  

Mesh:

Year:  2002        PMID: 12121361     DOI: 10.1046/j.1442-9071.2002.00528.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  10 in total

1.  Increased intraocular pressure on the first postoperative day following resident-performed cataract surgery.

Authors:  J Y Kim; M-W Jo; S C Brauner; Z Ferrufino-Ponce; R Ali; S L Cremers; B An Henderson
Journal:  Eye (Lond)       Date:  2011-04-29       Impact factor: 3.775

Review 2.  Topical medication instillation techniques for glaucoma.

Authors:  Li Xu; Xuemei Wang; Meijing Wu
Journal:  Cochrane Database Syst Rev       Date:  2017-02-20

3.  Cyclodestructive procedures for refractory glaucoma.

Authors:  Monica F Chen; Carole H Kim; Anne L Coleman
Journal:  Cochrane Database Syst Rev       Date:  2019-03-10

4.  Racioethnic differences in the biomechanical response of the lamina cribrosa.

Authors:  Reza Behkam; Hirut G Kollech; Anirban Jana; Amy Hill; Forest Danford; Stephen Howerton; Sundaresh Ram; Jeffrey J Rodríguez; Urs Utzinger; Christopher A Girkin; Jonathan P Vande Geest
Journal:  Acta Biomater       Date:  2019-02-20       Impact factor: 8.947

5.  Vascular risk factors in glaucoma: the results of a national survey.

Authors:  Nicola Orzalesi; Luca Rossetti; Stefano Omboni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-22       Impact factor: 3.535

6.  Comparison of newly diagnosed ocular hypertension and open-angle glaucoma: ocular variables, risk factors, and disease severity.

Authors:  Yvonne M Buys; Paul Harasymowycz; Rania Gaspo; Kenneth Kwok; Cindy M L Hutnik; Pierre Blondeau; Catherine M Birt; Robert L G Piemontesi; Lisa F Gould; Mark R Lesk; Iqbal K Ahmed
Journal:  J Ophthalmol       Date:  2011-08-18       Impact factor: 1.909

7.  Comprasion of ICare rebound tonometer and Goldmann applanation tonometer in high myopia.

Authors:  Halil Huseyin Cagatay; Metin Ekinci; Zeliha Yazar; Gokcen Gokce; Erdinc Ceylan
Journal:  ScientificWorldJournal       Date:  2014-10-14

8.  Is normal-tension glaucoma a risk factor for stroke?-A 10-year follow-up study.

Authors:  Meng-Sheng Lee; Li-Lin Kuo; Elise Chia-Hui Tan; Oscar K Lee
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

Review 9.  Glaucoma history and risk factors.

Authors:  Charles W McMonnies
Journal:  J Optom       Date:  2016-03-23

Review 10.  Migraine as a risk factor for primary open angle glaucoma: A systematic review and meta-analysis.

Authors:  Chang Xu; Jingjing Li; Zhi Li; Xiaochun Mao
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.